Comparison of the pharmacology of nafarelin and danazol
- PMID: 2137975
- DOI: 10.1016/0002-9378(90)90436-b
Comparison of the pharmacology of nafarelin and danazol
Abstract
The pharmacologic profiles of danazol and nafarelin differ considerably from each other. Danazol interacts with multiple classes of proteins, whereas the gonadotropin-releasing hormone agonist nafarelin interacts only with the pituitary gonadotropin-releasing hormone receptor. Differences in the molecular, endocrine, and clinical pharmacologic properties of these agents may provide clues to their varying effects in the management of women with endometriosis.
Similar articles
-
Effects of nafarelin versus danazol on lipids and calcium metabolism.Am J Obstet Gynecol. 1990 Feb;162(2):589-91. doi: 10.1016/0002-9378(90)90438-d. Am J Obstet Gynecol. 1990. PMID: 2137977 Clinical Trial.
-
Danazol: endocrine pharmacology and therapeutic applications.Am J Obstet Gynecol. 1981 Oct 15;141(4):453-63. doi: 10.1016/0002-9378(81)90611-6. Am J Obstet Gynecol. 1981. PMID: 7025640 Review.
-
Nafarelin versus danazol in the treatment of endometriosis.Am J Obstet Gynecol. 1990 Feb;162(2):586-8. doi: 10.1016/0002-9378(90)90437-c. Am J Obstet Gynecol. 1990. PMID: 2137976 Clinical Trial.
-
A comparative treatment trial of endometriosis using the gonadotrophin-releasing hormone agonist, nafarelin, and the synthetic steroid, danazol.Aust N Z J Obstet Gynaecol. 1991 May;31(2):158-63. doi: 10.1111/j.1479-828x.1991.tb01807.x. Aust N Z J Obstet Gynaecol. 1991. PMID: 1834049 Clinical Trial.
-
Pharmacologic management of endometriosis.Clin Pharm. 1991 Jul;10(7):518-31. Clin Pharm. 1991. PMID: 1830521 Review.
Cited by
-
Nafarelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical potential in sex hormone-related conditions.Drugs. 1990 Apr;39(4):523-51. doi: 10.2165/00003495-199039040-00005. Drugs. 1990. PMID: 2140979 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources